Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma
Clinical trial NCT01147822 · COMPLETED
Trial details
- NCT number
- NCT01147822
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-19
- Primary completion
- 2012-05-21
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.